Identification of extrasynaptic binding sites for [3H]GABA in peripheral nerve

Area of Science:

• Neuroscience
• Neuropharmacology
• Peripheral Nerve Research

Background:

• Gamma-aminobutyric acid (GABA) is a primary inhibitory neurotransmitter in the central nervous system.
• GABA also exerts depolarizing actions on peripheral myelinated axons, but the underlying receptor mechanisms are not fully understood.
• Extrasynaptic receptors play crucial roles in modulating neuronal excitability.

Purpose of the Study:

• To characterize the receptor species responsible for the depolarizing action of GABA on myelinated peripheral nerve axons.
• To identify and differentiate novel GABA binding sites in amphibian sciatic nerve homogenates.
• To compare the affinity of identified binding sites with the potency of GABA-evoked depolarization.

Main Methods:

• Radioligand binding assays using [3H]GABA on fresh homogenates of amphibian sciatic nerve under Na+-free conditions.
• Kinetic analysis of radioligand association to identify reversible and irreversible binding components.
• Scatchard plot analysis to determine the affinity (Kd) of reversible binding sites.
• Competitive binding studies using various GABA analogues and antagonists.

Main Results:

• Two distinct [3H]GABA binding sites were identified: one rapidly associating and reversible, the other slowly associating and apparently irreversible.
• The reversible binding component exhibited a high affinity (Kd = 22 nM), significantly higher than the ED50 for GABA-evoked depolarization (90 µM).
• Agonist competition revealed a specific rank order (muscimol > GABA > DAVA > β-alanine), but GABAA and GABAB specific ligands, as well as bicuculline and picrotoxin, did not displace the radioligand, indicating unique receptor properties.

Conclusions:

• The high-affinity [3H]GABA binding sites in peripheral nerve are unlikely to mediate the depolarizing action of GABA on myelinated axons due to the large difference in affinity.
• These identified binding sites are pharmacologically distinct from classical GABAA and GABAB receptors.
• The study suggests the existence of a novel, bicuculline-insensitive and baclofen-insensitive GABA receptor or binding site in the peripheral nervous system.